Theravance Biopharma
TBPH
#6225
Rank
$0.41 B
Marketcap
Cayman Islands
Country
$8.62
Share price
1.53%
Change (1 day)
-22.55%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Total assets
Total assets on the balance sheet as of March 2024 : $0.37 B
According to Theravance Biopharma 's latest financial reports the company's total assets are $0.37 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Theravance Biopharma - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.38 B | -37.11% |
| 2022-12-31 | $0.60 B | 62.05% |
| 2021-12-31 | $0.37 B | -20.09% |
| 2020-12-31 | $0.46 B | 14.73% |
| 2019-12-31 | $0.40 B | -27.03% |
| 2018-12-31 | $0.56 B | 26.92% |
| 2017-12-31 | $0.44 B | -30.95% |
| 2016-12-31 | $0.63 B | 113% |
| 2015-12-31 | $0.30 B | -11.15% |
| 2014-12-31 | $0.33 B | 1241.59% |
| 2013-12-31 | $25.17 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.65 B | 76.66% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $1.11 B | 200.09% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.64 B | 74.16% | 🇺🇸 USA |
 Catalent CTLT | $9.87 B | 2,560.60% | 🇺🇸 USA |